Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Aarhus Universitet Forside
Hjælp og OSS
English
Dansk
Forside
Profiler
Forskningsenheder
Projekter
Publikation
Priser
Aktiviteter
Kurser
Presse/medier
Søg efter ekspertise, navn eller tilknytning
Jan Alsner offentligt CV
Vis Scopus-profil
Jan Alsner
Chefkonsulent
,
Institut for Klinisk Medicin - Kræftafdelingen
https://orcid.org/0000-0002-5395-3193
Fastnet
+4561300131
E-mail
jan
oncology.au
dk
Palle Juul-Jensens Boulevard 35
8200
Aarhus N
Danmark
1990 …
2025
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Projekter
(2)
Publikation
(212)
Aktiviteter
(18)
Lignende profiler
(12)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Jan Alsner er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Radiation Therapy
100%
Breast Cancer
78%
Neoplasm
60%
Hypoxia
57%
Gene Expression
32%
Head and Neck Cancer
27%
Recurrent Disease
24%
Neck
24%
Squamous Cell Carcinoma
24%
Radiosensitivity
19%
Cancer Cell
17%
Overall Survival
17%
P16
15%
Head and Neck Squamous Cell Carcinoma
14%
Genome Wide Association Study
13%
Fibroblast
13%
Tumor Hypoxia
12%
Malignant Neoplasm
12%
Hazard Ratio
12%
Mastectomy
10%
Carbonate Dehydratase IX
10%
Metastatic Carcinoma
10%
Distant Metastasis
10%
Nimorazole
10%
Real-Time Polymerase Chain Reaction
10%
Bragg Peak
9%
Breast Radiotherapy
9%
Wart Virus
9%
Disease
9%
Patient-Reported Outcome
8%
DNA Topoisomerase (ATP Hydrolysing)
8%
Coronary Artery Disease
8%
Subgroup Analysis
8%
Bladder Cancer
8%
Partial Breast Irradiation
8%
Cobalt 60
8%
Lymph Node
8%
Protein P53
7%
Relative Biologic Effectiveness
7%
Formaldehyde
7%
Glucose Transporter 1
7%
Gene Expression Profiling
7%
Biological Marker
7%
Induration of Breast
7%
Disease Free Survival
7%
Adjuvant Radiotherapy
6%
Cancer Types
6%
In Vitro
6%
Prognostic Factor
6%
Cancer Mortality
6%
Biochemistry, Genetics and Molecular Biology
Gene Expression
52%
Overall Survival
25%
Radiosensitivity
24%
Fibroblast
21%
Real-Time Polymerase Chain Reaction
19%
MicroRNA
19%
P16
19%
Genetics
18%
Disease Specific Survival
17%
Radiogenomics
15%
Genome-Wide Association Study
15%
Single Nucleotide Polymorphism
14%
Tumor Hypoxia
13%
Retinoblastoma
13%
Epidermal Growth Factor Receptor
13%
Single-Nucleotide Polymorphism
11%
Gene Expression Profiling
10%
Cancer Stem Cell
10%
Gene Signature
10%
Proton Radiation
10%
Differential Gene Expression
9%
Genetic Screening
9%
Wart Virus
9%
Messenger RNA
8%
Topoisomerase
8%
Proteomics
8%
DNA Topoisomerase
8%
Genome Wide Association Study
8%
Cobalt-60
8%
Tumor Volume
8%
Genetic Divergence
7%
Gene Expression Data
7%
Gene Expression Level
7%
Genotyping
7%
Candidate Gene
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Gene Mutation
7%
Stem Cell Marker
6%
Proteome
6%
TGF Beta 1
6%
Allele
6%
Cancer Cell
6%
Linear Energy Transfer
6%
Upregulation
5%
Clinical Trial
5%
Microarrays
5%
Angiogenesis
5%
Retrospective Study
5%
Estrogen Receptor
5%
Mouse
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
51%
Breast Cancer
48%
Head and Neck Cancer
35%
Hypoxia
18%
Radiation Induced Fibrosis
17%
Malignant Neoplasm
15%
Squamous Cell Carcinoma
14%
Overall Survival
13%
Head and Neck Squamous Cell Carcinoma
12%
Disease
11%
Recurrent Disease
11%
Prostate Cancer
8%
Cobalt 60
8%
Protein P53
8%
Acute Toxicity
8%
Mouse
7%
Biological Marker
7%
Carcinoma
6%
Nimorazole
6%
Fibrosis
6%
Disease Specific Survival
5%
